root
rhizom
glycyrrhiza
speci
licoric
wide
use
natur
sweeten
herbal
medicin
aim
studi
investig
effect
glycyrrhiz
acid
ga
licoric
macrophag
polar
phenotyp
function
activ
murin
bone
marrowderiv
macrophag
bmdm
treat
ga
assess
result
show
ga
obvious
increas
cell
surfac
express
mhcii
molecul
meanwhil
ga
upregul
express
product
tnf
marker
classic
activ
macrophag
wherea
downregul
express
mr
marker
altern
activ
macrophag
function
test
show
ga
dramat
enhanc
uptak
fitcdextran
e
coli
bmdm
decreas
intracellular
surviv
e
coli
typhimurium
moreov
demonstr
jnk
nfb
activ
requir
gainduc
cytokin
product
pathway
exhibit
regulatori
effect
via
induct
togeth
find
indic
ga
promot
polar
macrophag
enhanc
phagocytosi
bactericid
capac
result
expand
knowledg
role
ga
macrophag
polar
licoric
root
glycyrrhiza
uralensi
wellrecogn
natur
sweeten
use
tradit
herbal
medicin
treatment
variou
patholog
condit
includ
allergi
liver
diseas
gastric
ulcer
adren
insuffici
number
compon
isol
licoric
includ
triterpen
saponin
flavonoid
polysaccharid
substanc
glycyrrhiz
acid
ga
major
biolog
activ
constitu
licoric
root
account
sweet
tast
triterpen
glycosid
contain
one
molecul
acid
two
molecul
glucuron
acid
far
ga
report
varieti
pharmacolog
activ
like
antivir
antitumor
antiinflammatori
antioxid
activ
shown
ga
promot
function
endotheli
system
secret
cytokin
interleukin
il
interferon
ifn
induc
matur
dendrit
cell
dc
increas
cell
prolifer
product
ifn
augment
natur
killer
nk
cell
activ
enhanc
phagocyt
capac
nitric
oxid
product
activ
macrophag
downregul
product
human
lung
fibroblast
cell
studi
indic
ga
may
serv
immun
modul
precis
regul
cellular
immun
macrophag
long
consid
import
effector
cell
play
key
role
host
defens
homeostasi
depend
microenviron
macrophag
acquir
distinct
morpholog
function
properti
two
extrem
spectrum
macrophag
phenotyp
often
refer
classic
activ
macrophag
altern
activ
macrophag
phenotyp
polar
cytokin
ifnand
character
high
capac
present
antigen
high
level
inflammatori
cytokin
tnf
secret
increas
level
product
enhanc
capac
kill
intracellular
pathogen
tumor
cell
promot
polar
respons
contrast
macrophag
polar
cytokin
character
minim
product
inflammatori
molecul
increas
express
mannos
receptor
mr
chitinaselik
found
inflammatori
cell
associ
antiinflammatori
homeostat
function
link
wound
heal
tissu
remodel
repair
scaveng
debri
particip
polar
reaction
gener
macrophag
consid
proinflammatori
cell
wherea
macrophag
antiinflammatori
howev
limit
inform
ga
regul
phenotyp
macrophag
present
studi
investig
effect
ga
polar
murin
bone
marrowderiv
macrophag
bmdm
found
ga
promot
rather
macrophag
polar
enhanc
phagocytosi
bacteri
kill
capac
demonstr
gamedi
macrophag
polar
involv
activ
mitogenactiv
protein
kinas
mapk
nuclear
factorb
nfb
pathway
elisa
kit
tnf
obtain
ebiosci
san
diego
ca
usa
antibodi
actin
ino
phosphojnk
jnk
mapk
mapk
b
hrpconjug
antimous
antigoat
igg
purchas
santa
cruz
biotech
santa
cruz
ca
usa
antibodi
obtain
bd
pharmingen
san
jose
ca
usa
inhibitor
bay
purchas
beyotim
biotechnolog
haimen
jiangsu
china
anim
mice
week
old
purchas
slac
anim
inc
shanghai
china
rear
experiment
anim
center
zhejiang
univers
experiment
protocol
anim
studi
approv
institut
anim
care
use
committe
zhejiang
univers
bmdm
prepar
bmdm
modifi
previous
describ
method
briefli
mice
kill
cervic
disloc
femur
tibia
hind
leg
dissect
bone
marrow
caviti
flush
ml
cold
steril
phosphat
buffer
salin
pb
lyse
red
blood
cell
bone
marrow
cell
wash
resuspend
differenti
bmdm
dmem
fb
ngml
mcsf
gml
streptomycin
uml
penicillin
six
day
initi
bmdm
cell
cultur
puriti
cell
determin
flow
cytometri
fac
monolay
bmdm
micropl
cultur
dmem
supplement
fb
incub
ga
gml
h
medium
replac
fresh
dmem
contain
mgml
mtt
h
incub
supernat
remov
precipit
dissolv
dmso
final
optic
densiti
measur
use
spectramax
md
od
lactat
dehydrogenas
ldh
releas
damag
cell
determin
h
treatment
pb
blank
control
ga
gml
ifn
ngml
lp
ngml
control
ngml
control
ldh
activ
cultur
supernat
measur
previous
describ
detect
cell
surfac
express
cc
chemokin
receptor
mr
mhc
class
ii
mhcii
cell
differ
treatment
group
respect
collect
stain
antibodi
mr
mhcii
min
c
wash
twice
pb
analyz
facscalibur
flow
cytomet
bectondickinson
total
rna
isol
bmdm
rnaiso
plu
takara
reversetranscrib
use
primescript
ii
strand
cdna
synthesi
kit
takara
realtim
pcr
perform
use
sybr
premix
ex
taq
ii
takara
abi
realtim
pcr
system
appli
biosystem
follow
primer
use
tnfforward
revers
forward
revers
assay
level
tnf
cultur
supernat
quantifi
use
sandwich
elisa
kit
ebiosci
per
manufactur
instruct
blot
analysi
total
cell
lysat
prepar
previous
describ
nuclear
cytosol
extract
fraction
use
nuclear
cytoplasm
protein
extract
kit
beyotim
biotechnolog
accord
manufactur
instruct
equal
amount
protein
sampl
subject
sdspage
follow
transfer
protein
nitrocellulos
membran
membran
block
protein
block
solut
sangon
biotech
incub
primari
antibodi
overnight
c
wash
tbst
membran
incub
secondari
antibodi
link
hrp
blot
develop
ecl
detect
system
per
manufactur
instruct
nitrit
accumul
cultur
supernat
measur
griess
method
cellfre
cultur
supernat
mix
l
sulfanilamid
n
ethylenediamin
dihydrochlorid
phosphor
acid
absorb
read
within
min
nm
actual
concentr
calcul
use
standard
curv
serial
dilut
sodium
nitrit
analyz
phagocyt
activ
macrophag
bmdm
pretreat
ga
gml
h
incub
fitcdextran
mgml
c
h
incub
cell
wash
twice
pb
percentag
mean
fluoresc
intens
mfi
intracellular
fitcdextran
determin
fac
determin
bactericid
function
macrophag
bmdm
seed
cellswel
cultur
plate
corn
pretreat
ga
gml
h
cell
wash
incub
escherichia
coli
e
coli
stain
salmonella
typhimurium
typhimurium
strain
h
c
allow
bacteri
adhes
colon
thereaft
cell
thoroughli
wash
pb
incub
h
h
dmem
contain
gentamicin
gml
final
cell
lysat
bmdm
contain
intracellular
bacteria
serial
dilut
pb
spread
onto
lb
agar
plate
determin
bacteri
viabil
result
present
mean
sd
three
independ
experi
statist
analys
perform
use
twotail
student
test
valu
consid
signific
evalu
cytotox
ga
rang
gml
bmdm
found
optim
viabil
gml
show
surviv
figur
moreov
confirm
cell
damag
treatment
use
follow
experi
measur
releas
cytosol
marker
ldh
treatment
ga
gml
ifn
ngml
lp
ngml
h
show
signific
differ
ldh
releas
compar
control
group
ngml
significantli
decreas
ldh
releas
figur
b
therefor
gml
ga
use
next
experi
activ
macrophag
abl
present
antigen
cell
induc
effect
cell
respons
one
defin
characterist
effici
antigenpres
cell
express
mhcii
costimulatori
molecul
like
investig
whether
ga
regul
express
molecul
macrophag
bmdm
incub
ga
gml
h
shown
figur
percentag
mhcii
express
ga
treatment
upregul
respect
meanwhil
intens
express
three
molecul
significantli
enhanc
ga
treatment
data
demonstr
bmdm
activ
effect
induc
dose
ga
gml
studi
effect
ga
bmdm
polar
first
cell
imag
captur
h
treatment
bmdm
control
group
oval
irregularli
shape
cell
clear
cell
border
gatreat
cell
exhibit
pit
vacuol
close
attach
button
less
distinct
cell
border
shown
figur
morpholog
characterist
gatreat
cell
similar
group
confirm
whether
ga
mediat
macrophag
polar
bmdm
examin
express
marker
figur
fac
analysi
demonstr
ga
markedli
increas
express
surfac
marker
wherea
decreas
express
surfac
marker
mr
figur
furthermor
ga
upregul
express
cytokin
tnf
mrna
protein
level
howev
ga
downregul
mrna
express
marker
mr
figur
b
c
result
indic
ga
promot
typic
activ
phenotyp
bmdm
produc
compet
ino
substrat
arginin
thu
decreas
gener
investig
whether
ga
regul
product
bmdm
shown
figur
ino
gene
product
reciproc
regul
ga
treatment
follow
ino
mrna
express
induc
ga
detect
h
increas
peak
h
wherea
mrna
decreas
ga
basal
level
control
h
anticip
also
observ
ga
obvious
enhanc
ino
protein
express
bmdm
dosedepend
manner
figur
b
accordingli
gener
gatreat
group
significantli
higher
control
group
figur
c
summari
data
support
notion
ga
could
promot
macrophag
polar
bmdm
capac
bmdm
phagocytosi
bacteri
kill
play
crucial
role
macrophagemedi
host
defens
lead
intern
destruct
pathogen
determin
whether
ga
trigger
function
bmdm
first
examin
intern
fitclabel
dextran
fac
bmdm
pretreat
ga
h
show
markedli
increas
uptak
fitcdextran
compar
control
group
figur
support
find
evalu
effect
ga
uptak
e
coli
typhimurium
bmdm
interestingli
ga
significantli
increas
uptak
extracellular
bacteria
e
coli
compar
control
group
intern
intracellular
bacteria
typhimurium
signific
differ
gatreat
group
control
group
figur
b
inconsist
result
e
coli
typhimurium
intern
bmdm
may
result
mechan
typhimurium
effici
invad
macrophag
bacteria
intern
bmdm
examin
bactericid
capac
macrophag
shown
figur
b
ga
markedli
reduc
bacteri
surviv
e
coli
typhimurium
infect
model
rel
control
group
respect
sum
result
demonstr
ga
could
enhanc
phagocyt
bactericid
capac
bmdm
macrophag
polar
complex
process
includ
stimuli
recognit
activ
transcript
factor
figur
effect
ga
bmdm
phagocytosi
bactericid
activ
bmdm
pretreat
ga
gml
h
incub
fitcdextran
c
h
intracellular
fitcdextran
measur
fac
b
infect
e
coli
typhimurium
h
wash
incub
dmem
gentamicin
gml
h
h
cell
lyse
dilut
plate
lb
plate
coloni
enumer
data
mean
sd
three
independ
experi
test
recent
studi
shown
mapk
nfb
signal
pathway
involv
macrophag
polar
investig
whether
ga
activ
cascad
perform
western
blot
examin
phosphoryl
mapk
nuclear
transloc
nfb
treatment
ga
led
rapid
transient
increas
phosphoryl
form
three
mapk
bmdm
phosphoryl
reach
peak
min
treatment
declin
almost
basal
level
within
min
figur
also
observ
ga
trigger
gradual
increas
nfb
protein
nucleu
correspondingli
decreas
b
protein
cytosol
within
min
stimul
figur
b
howev
ga
induc
phosphoryl
bmdm
figur
c
indic
gamedi
macrophag
polar
independ
signal
next
determin
role
mapk
nfb
activ
gainduc
macrophag
polar
bmdm
respect
pretreat
pharmacolog
inhibitor
min
incub
ga
h
shown
figur
bay
nfb
jnk
mapk
significantli
decreas
gainduc
product
cytokin
shown
exampl
wherea
pretreat
result
unexpect
increas
cytokin
product
furthermor
inhibit
pathway
led
mark
decreas
express
mrna
protein
level
figur
togeth
data
thu
indic
nfb
jnk
activ
requir
gainduc
macrophag
polar
pathway
exhibit
regulatori
effect
via
induct
inhibitori
factor
macrophag
extrem
heterogen
lineag
display
rang
proand
antiinflammatori
function
function
phenotyp
obtain
macrophag
depend
upon
interact
specif
stimuli
endogen
exogen
environ
howev
unlik
cell
undergo
extens
epigenet
modif
differenti
macrophag
seem
retain
plastic
respond
environment
signal
previou
studi
observ
phenotyp
switch
phenotyp
macrophag
popul
occur
patholog
process
cancer
moreov
pathogen
francisella
tularensi
leishmania
major
abl
redirect
phenotyp
macrophag
consequ
surviv
expens
host
therefor
target
macrophag
phenotyp
plastic
may
provid
novel
therapeut
strategi
diseas
infect
investig
effect
ga
phenotyp
polar
macrophag
data
show
ga
markedli
increas
express
mhcii
molecul
associ
antigen
present
lymphocyt
activ
similar
result
obtain
gatreat
dc
induc
respons
analyz
express
marker
bmdm
found
ga
significantli
upregul
express
tnf
relat
macrophag
wherea
ga
downregul
express
marker
mr
result
agreement
previou
studi
ga
exhibit
stimulatori
effect
coronaviru
leishmania
donovani
infect
periton
macrophag
via
induct
proinflammatori
effector
metabol
import
distinct
macrophag
macrophag
produc
high
level
ino
synthes
arginin
macrophag
counteract
ino
activ
produc
degrad
arginin
urea
ornithin
thu
reduc
product
observ
ga
reciproc
regul
express
ino
bmdm
led
increas
product
result
support
report
ga
enhanc
product
ifn
activ
macrophag
moreov
macrophag
known
potent
effector
cell
enhanc
phagocytosi
bactericid
capac
consist
notion
ga
enhanc
uptak
fitcdextran
e
coli
bmdm
markedli
decreas
intracellular
surviv
e
coli
typhimurium
best
knowledg
previou
report
bacteri
kill
capac
gatreat
macrophag
data
provid
evid
ga
exhibit
protect
effect
host
defens
intracellular
microorgan
mediat
function
polar
macrophag
sinc
macrophag
polar
requir
activ
specif
transcript
factor
possibl
pathway
involv
gapolar
macrophag
could
care
identifi
known
mapk
erk
jnk
mapk
regul
variou
inflammatori
cytokin
express
phosphoryl
transcript
factor
nfb
protein
detach
inhibitor
bs
activ
transloc
cytoplasm
nucleu
final
regul
transcript
larg
number
gene
found
ga
induc
phosphoryl
three
mapk
accompani
nuclear
transloc
nfb
inhibit
jnk
nfb
activ
respect
inhibitor
significantli
decreas
gainduc
product
cytokin
recent
studi
demonstr
jnk
requir
macrophag
polar
hfdfed
mice
defici
jnk
led
decreas
express
gene
increas
express
gene
adipos
tissu
macrophag
addit
nfb
pathway
also
report
associ
macrophag
polar
inhibit
mapk
effect
gainduc
marker
howev
inhibit
result
unexpect
increas
cytokin
product
seem
regul
limit
inflamm
via
induct
antiinflammatori
cytokin
confirm
inhibit
markedli
decreas
gainduc
express
bmdm
sum
jnk
nfb
activ
requir
gainduc
macrophag
polar
pathway
exhibit
regulatori
effect
prevent
excess
inflamm
also
note
studi
report
ga
inhibit
induct
proinflammatori
effector
induc
tlr
tolllik
receptor
agonist
eg
cpgdna
lp
fact
antiinflammatori
activ
ga
may
result
chang
cell
membran
thu
attenu
membranedepend
receptor
signal
instanc
ga
decreas
cellular
attach
uptak
cpgdna
strongli
impair
lpsinduc
homodimer
raw
cell
demonstr
ga
exhibit
stimulatori
effect
rather
inhibitori
effect
bmdm
skew
macrophag
polar
bia
still
unclear
macrophag
recogn
ga
interact
ga
cell
membran
observ
data
show
clear
relationship
ga
macrophag
polar
known
import
clearanc
intracellular
pathogen
tumor
cell
phenotyp
macrophag
popul
appear
chang
specif
stimuli
ga
might
use
therapeut
diseas
infect
convert
macrophag
popul
phenotyp
henc
would
interest
introduc
vivo
vitro
studi
explor
role
ga
model
conclus
demonstr
novel
role
ga
polar
macrophag
find
might
give
new
insight
function
ga
immun
system
highlight
clinic
signific
ga
posit
modul
respons
pathogen
invas
